Masanobu Saruta

Real world evidence of enfortumab vedotin in patients with advanced urothelial cancer: A multicenter observational study

Wataru Fukuokaya, Yuhei Koike, Yuji Yata et al. · International Journal of Urology · 2023 · 29 citations

Medicine, Oncology, Pharmacotherapy +17

Comparing pentafecta outcomes between nerve sparing and non nerve sparing robot-assisted radical prostatectomy in a propensity score-matched study

Tanan Bejrananda, Kiyoshi Takahara, Dutsadee Sowanthip et al. · Scientific Reports · 2023 · 24 citations · Full text

Medicine, Surgery, Urology +17

Comparison of the efficacy of enfortumab vedotin between patients with metastatic urothelial carcinoma who were treated with avelumab or pembrolizumab: real-world data from a multi-institutional study in Japan

Yosuke Hirasawa, Takahiro Adachi, Takeshi Hashimoto et al. · Journal of Cancer Research and Clinical Oncology · 2024 · 21 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

C-Reactive Protein-Albumin Ratio Predicts Objective Response to Enfortumab Vedotin in Metastatic Urothelial Carcinoma

Taizo Uchimoto, Takuya Matsuda, Kazumasa Komura et al. · Targeted Oncology · 2024 · 11 citations

Medicine, Oncology, Pharmacology +14

Predicting time to castration resistance with androgen-receptor signaling inhibitors in hormone-sensitive prostate cancer: data from ULTRA-Japan Consortium

Taizo Uchimoto, Kengo Iwatsuki, Kazumasa Komura et al. · International Journal of Clinical Oncology · 2024 · 10 citations

Medicine, Oncology, Urology +14